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The adrenal glands have long been suggested as having a protective 
action in anaphylactic shock.  Anderson and Schultz (1) and Pelz and 
Jackson (2) showed the importance of adrenalin in early stages of ex- 
perimental shock, and extensive clinical experience seems to warrant its 
continued use as an emergency treatment.  Kepinow (3), working with 
guinea pigs, and Flashman (4), working with rats, both found that a 
smaller dose of antigen induced fatal shock in adrenalectomlzed ani- 
mals.  The latter reported that adrenalectomy either before or after 
sensitization had the same effect, which was proportional to the degree 
of adrenal insufficiency present.  Wyman (5) confirmed these results, 
and his work led him to believe that the lack of medullary tissue was 
the deciding factor in the increase of susceptibility.  Perla and Mar- 
morston-Gottesman (6),  working with the closely related histamine 
shock, found that the resistance of adrenalectomized rats to histamine 
was raised by the administration of a number of doses of cortin. 
We were led to determine what protective effect adrenal cortex ex- 
tracts might have in experimental anaphylactic shock in non-operated 
animals.  On theoretical grounds our attempt was feasible.  In cor- 
ticoadrenal insufficiency there is  a  disturbed electrolyte metabolism 
which accompanies changes in  cell permeability.  This is  corrected 
by  parenteral  administration of  cortin  (7).  In  anaphylactic shock 
also, the syndrome can be explained, at least partially, on a disturbed 
permeability basis.  Furthermore, in  both experimental adrenal  in- 
sufficiency (8)  and anaphylactic shock (9-13) many of the symptoms 
are alleviated or postponed by the administration of sodium salts. 
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Material and Methods 
Fifty-eight young guinea pigs weighing  between 250 and 400 gin.  were used. 
They were kept in large cages and fed a  diet of oats, hay, lettuce,  and water. 
Nine were  used for variable dosage tests,  thirty-three were cortin-treated,  and 
sixteen were test controls. 
Purified,  three times recrystanized egg albumin,  1 was chosen as a sensitizing and 
shocking agent by reason of its being a single antigen.  A sensitizing dose of 1 rag. 
of egg albumin was given intraperitoneally to all animals.  The interval between 
sensitizing dose and shocking  dose was in each case 14 days. 
A few preliminary experiments using from 5 to 40 rag. doses showed that 13 mg. 
given  intraperitoneally  would  cause  fatal  anaphylactic  shock  in  less  than  35 
minutes.  This was the amount used for all controls and all cortin-treated animals. 
Controls were included whenever a series of cortin-treated animals received shock- 
ing doses. 
The cortin was prepared by one of us from fresh beef adrenals and was made up 
in normal saline  solution.  Extract prepared according to two different methods 
did not alter the results significantly.  Both  types had been proven potent by 
administration to adrenalectomized cats.  Each guinea pig received a single dose 
of 3 cc. of a  solution of the hormone in the muscles of a hind leg.  The interval 
between injection of cortin and the injection of the shocking dose varied in different 
cases between 1 hour and 27 hours.  Some of the controls received Ringer solution 
in amounts equivalent to the cortin given, with no differences in their reactions. 
l~SULTS 
Sixteen control animals were used and fourteen of these died in less 
than  35  minutes  (Table I).  A  typical case  (B  15)  showed  the  usual 
first  signs  of  shock  and  was  weak  and  recumbent  within  5  minutes 
after the  intraperitoneal  injection  of the  antigen  dose.  The  charac- 
teristic  spasmodic  breathing  began  5  minutes  later,  increased  in  in- 
tensity,  and  24  minutes  after the  administration  of the  albumin  the 
animal was dead.  Two animals that  survived  (B 41  and B  42)  were 
found  at  autopsy to  have adrenals  larger than  normal.  Two others 
intended  for use in  the  control  series  survived  longer  than  1/~ hour. 
The  autopsies  showed  definite  lung  infections.  All  other  animals 
that had been kept with these were autopsied carefully after use,  and 
1 This was kindly furnished by Dr. M. Heidelberger of the Department of Bio- 
logical  Chemistry, whom we take this opportunity to thank.  We also wish  to 
thank Dr. Beatrice Seegal of the Department of Bacteriology for advice at the 
beginning of these experiments, and Mr. John S. Wolf for his help in some of the 
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the  results  from  control and  cortin-treated  guinea  pigs  that  showed 
any lung consolidation at all were discarded. ~ 
The time interval  between the administration  of cortin  and of egg 
albumin proved to be important  (Table I).  The greatest amount of 
protection was seen when the cortin was given from 2 to 6 hours be- 
fore the albumin.  If the interval was shorter or if it was much longer, 
the  degree  of protection  was  greatly  diminished.  There  was  some 
evidence of protection when the period was only a few hours longer, as 
in the 11 hour group. 
Of the sixteen animals given cortin 2 to 6 hours before the antigen, 
nine survived indefinitely, two lived about an hour, and the other five 
died in less than 35 minutes. 
In a  1 to  1½ hour group of six animals,  the longest survival period 
was ~  hour.  In the  11 hour group of four guinea  pigs,  one survived 
indefinitely, one lived 1 hour, and two lived less than  35 minutes.  A 
17 to 27 hour group of seven showed three survivals for approximately 
an hour. 
In the seven guinea pigs surviving 45 to 64 minutes the appearance 
of the behavior usually considered as typical of anaphylactic shock was 
delayed in each case until  a  few minutes before death.  Up to  that 
time  they were quite weak and  lay quietly on  their  sides, but were 
strong  enough  to  move  about  fairly  actively  when  repeatedly  dis- 
turbed. 
The ten animals that survived did not pass into marked shock.  One 
showed no weakness, and no signs of shock whatsoever.  The others 
were weak for a perio  d which was at the longest 15 minutes, and then 
began to show slight signs of shock.  These persisted in some cases for 
a considerable time; in others they were evanescent and consisted only 
of one or two gasps or sniffles.  Usually weakness continued  for a few 
minutes after the signs of shock had  disappeared.  By 1½ hours after 
the injection of the albumin all the animals had  recovered su/ficiently 
to be interested in eating and drinking. 
The infected animals when considered by themselves confirm the results of 
the non-infected groups, but were not included in our tables nor in the total of 
animals used.  The results obtained seem to confirm the view based on both experi- 
mental and clinical evidence that allergic manifestations are inhibited by general 
infection. TABLE  I 
Cortin Protection against Anaphylactic  Shock 
1 rag. sensitizing dose and 13 nag. shocking dose given intraperitoneally in all 
cases.  All treated animals received a  single intramuscular injection of 3  co.  of 
cortin. 
Control animal 
B 33 
B 32 
B 35 
B44 
B  13 
B  15 
]3 12 
B  14 
B3 
B7 
A 36 
A3 
A2 
B 33 
B 32 
B 35 
B  50 
B 41 
B42 
7 
Survival  time 
mln. 
18 
26 
26 
25 
23 
24 
26 
28 
13' 
34 
17 
5 
10 
2  * 
26j 
20 
Survived 
Survived 
Cortin-treated 
animal 
B 34 
B31 
B 36 
B43 
B48 
B46 
A21 
B 20 
B  16 
]317 
B  19 
B  18 
Bll 
B1 
B2 
B8 
A 33 
A 32 
A7 
A5 
A4 
A1 
B 38 
B 37 
B40 
B 39 
B 49 
B 47 
B 45 
B6 
B  10 
B9 
A6 
Interval between 
cortin and shock- 
ing injections 
hrs. 
1 
1 
1 
1½ 
1½ 
1½ 
2~ 
3] 
3½ 
3½ 
3½ 
3½ 
3½ 
3½ 
3½ 
3~ 
4½ 
4½ 
31 
4½ 
5½ 
ii 
ii 
II 
II 
17 
17 
17 
24 
24 
24 
27 
Survival time 
31 
33 
38 
24 
27 
46 
Survived 
18 
27 
34 
Survived 
Survived 
Survived 
64 
Survived 
Survived 
Survived 
Survived 
56 
Survived 
20 
23 
17 
30 
j  60 
Survived 
25 
31 
55 
14 
60 
i  63 
41 
* Same controls as above. 
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Eight of the cortin-treated  animals that  survived a  usually fatal 
antigen dose were injected again with 13 mg. of egg albumin after 14 
days (Table II).  Seven of these died in shock; the other became weak 
quickly, showed first signs of shock at 5 minutes and had difficulty in 
breathing.  It was killed after  1] hours, at which time it was very 
weak and showed marked dyspnea.  This experiment shows that the 
cortin protection is not a permanent desensitization and also indicates 
that the original survival was a result of treatment and not the chance 
individual peculiarity of the animals. 
TABLE  II 
Fate of Ten Cortin Survivors 
A~mal No.  Survival time 
A5 
B 39 
B2 
Bll 
B  19 
A21 
B8 
B  18 
A 32 
A 33 
10 
28 
30 
32 
37 
68 
83 
Signs of shock in a few minutes.  Killed after 1~ hrs. 
Autopsied (negative) 
Autopsied (negative)" 
Seven of eight given second injection died of shock.  This shows that cortin 
protection is not prolonged and also that these animals were sensitive to shock. 
Studies have been made on the microscopic anatomy of the adrenal 
glands from control, untreated guinea pigs dying of shock.  These 
suggest that there is an acute demand (14) on the adrenal cortex dur- 
ing  shock.  A  few  preliminary  blood  chemical determinations also 
indicate that changes are taking place which can to some extent be 
remedied by  the survival hormone of  the  adrenal  cortex.  We  are 
continuing these studies on anaphylactic shock and on the relation of 
the adrenal cortex to other allergic phenomena. 
DISCUSSION 
The combined evidence of many investigations shows that the ad- 
renal glands are involved in natural anti-anaphylactic efforts of the 14  CORTIN PROTECTION  AGAINST  SHOCK 
body.  We feel, however, that emphasis laid on the r61e of the medulla 
has obscured the part  played by  the  cortex.  The foregoing experi- 
ments show that corticoadrenal extracts by themselves have a definite 
anti-anaphylactic  value.  Cortin has also  been used with some suc- 
cess in the closely related histamine shock  (6)  and in a  few cases of 
traumatic shock (15). 
We believe that the natural protective action involves first the cor- 
tex  and  then  the  medulla.  The  speed,  duration  and  extent  of  the 
changes produced by adrenalin and cortin have been shown to differ 
in respect to carbon dioxide capacity  (7)  and carbohydrate mobiliza- 
tion  (16).  The same thing appears  to be true in anaphylaxis.  The 
use of adrenalin has been found to  be  most effective at  the  time of 
shocking, whereas in our experience cortin is best used several hours 
earlier.  Cortin appears to have a  general effect on the syndrome of 
shock, whereas adrenalin  (as well as atropine) seems to have a  symp- 
tomatic effect on allergic phenomena. 
In  experimental  anaphylactic  and  other  types  of  shock,  certain 
blood changes have been described.  There is a  lowered  carbon diox- 
ide capacity  (10,  17), a  decreased plasma volume (18,  15),  and a  rise 
in serum potassium (19).  In experimental adrenal insufficiency also, 
one finds a low carbon dioxide capacity (7), diminished plasma volume 
(18,  15), and a high serum potassium  (20, 7).  Conversely, cortin in- 
jection is followed by  increased  carbon  dioxide capacity  (21,  22,  7) 
and plasma volume  (15)  and  a  lowered serum  potassium  (7).  Fur- 
thermore, the low carbon dioxide  capacity in adrenal insufficiency is 
associated with a loss of serum sodium and the latter is also increased 
after cortin administration (7).  In experiments on both anaphylactic 
shock (9-13)  and adrenal insufficiency (8)  it has  been found that the 
use of relatively large  amounts of sodium salts was of some benefit. 
There seems to be a similarity in the blood changes of both conditions. 
In the absence of more definite information, we suggest that cortin 
protects  from anaphylactic  shock by  reason  of  its  regulatory  effect 
upon ionic and other changes dangerous to the health of the organism. 
SU'M-~ARY 
Studies have been made on a possible protective action of cortin in 
the  prevention  of  anaphylactic  shock  induced  by  crystallized  egg 
albumin. 7-  WOLFRAM AND  R.  L.  ZWEMEk  15 
Of sixteen control guinea pigs only two survived. 
Sixteen of thirty-three cortin-treated animals received hormone at 
the optimum period of from 2 to 6 hours before the shocking dose. 
Nine survived and two others showed some  protection.  In groups 
treated  at  other  time  intervals  the  evidence  of  protection  is 
inconclusive. 
2 weeks after the first test the cortin-treated survivors succumbed to 
a second antigen dose, which was not preceded by cortical extract. 
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